FAKTOR OPTIONSSCHEIN - AMGEN | Real-time Boerse Frankfurt Warrants 12:28:15 2024-07-12 pm EDT | ||
| 4.22 EUR | -4.95% |
|
| Current month | -12.94% | ||
| 1 month | -23.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 4.22 | -4.95% |
| 24-07-11 | 4.44 | -4.93% |
| 24-07-10 | 4.67 | -7.16% |
| 24-07-09 | 5.03 | -2.33% |
| 24-07-08 | 5.15 | -1.15% |
Real-time Boerse Frankfurt Warrants
Last update July 12, 2024 at 12:28 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM1ZQ8 |
| ISIN | DE000UM1ZQ81 |
| Date issued | 2024-02-20 |
| Strike | 433.5 $ |
| Maturity | Unlimited |
| Parity | 21.83 : 1 |
| Emission price | 8.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.15 € |
|---|---|
| Lowest since issue | 4.22 € |
| Spread | 0.15 € |
| Spread % | 3.43% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
325.1
USD
Average target price
316.1
USD
Spread / Average Target
-2.75%
- Stock Market
- Certificates
- Certificat
